Biogen Inc said the approval of its Alzheimer's disease drug was based on extensive data as it seeks to quell concerns about the drug's effectiveness
Shares of Eli Lilly and Co. jumped more than 8%, or $18.59, to $235.69 at the opening bell Thursday.
By Deena BeasleyBiogen's drug had been hailed by patient advocates and some neurologists eager to have an effective option for patients with the lethal disease.
Scientists have recorded blood oxygen levels in the hippocampus and provided experimental proof for why the area is vulnerable to damage and degeneration, a precursor to Alzheimer's disease
Researchers used a genetic engineering strategy to reduce levels of tau--a key protein that accumulates and tangles in brain during the development of Alzheimer's--in an animal model of the condition
A panel of outside advisers to the US FDA voted that a potential Alzheimer's treatment from Biogen has not been proven to slow the progression of the disease
One of the biggest drug decisions in decades is looming as US regulators consider whether to approve the first medicine that's claimed to slow mental decline from Alzheimer's disease
Artificial intelligence can diagnose Alzheimer's disease faster and improve prognosis, a new study has revealed
The aim of the researchers was to pinpoint potential factors that could reduce Alzheimer's disease risk
The number of people in the United States living with Alzheimer's, the most common form of dementia, is expected to triple to nearly 14 million by 2050 without effective treatments
PET imaging is expensive and involves radioactive agents, and spinal fluid tests require spinal taps, which are invasive, complex and time-consuming, they said.
The study, in PLOS Medicine, measured drinking in "standard drinks" - 12 ounces of beer, five ounces of wine, or one-and-a-half ounces of hard liquor.
Extracted from brown algae, the medicine is said to be the world's first innovative therapy for the treatment of Alzheimer's disease in 17 years
There is a blood test on the horizon that can detect beta amyloid, and researchers are experimenting with scans to look for another protein, called tau, also characteristic of Alzheimer's
The latest results strengthen Grifols' research on plasma protein replacement therapies
The drug is the only Alzheimer's medicine out of more than 320 developed by pharmaceutical companies around the globe to survive clinical trials, according to reports
Some experts fear PET scans offer few benefits, at substantial costs
The findings, published in the journal Hypertension, indicate that the known decrease in cerebral blood flow in patients with Alzheimer's can be reversed in some regions
Virgin Coconut Oil (VCNO) is obtained from fresh, matured kernel of the coconut
More extensive trials will be needed to know if the new drug is truly effective